Showing results (391-400 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|September 24, 2023
Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activityChristopher B Lietz, Ekaterina Deyanova, Younhee Cho, et al.
Mabs|September 22, 2023
Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregatesInga Petersen, Muhammad Ilyas Ali, Alex Petrovic, et al.
Mabs|September 8, 2023
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretionYoshiyuki Arata, Shigeki Motoyama, Mariko Yano, et al.
Mabs|September 12, 2023
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodiesMarissa Mock, Alex W Jacobitz, Christopher James Langmead, et al.
Mabs|September 12, 2023
Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disordersStephanie Maciuba, Gregory D Bowden, Harrison J Stratton, et al.
Mabs|June 19, 2023
A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activationAlessandro Mega, Aman Mebrahtu, Gustav Aniander, et al.
Mabs|March 10, 2026
Using mass spectrometry for robust identity release testing in a global quality control networkSebastien Leibe, Sebastien Violini, Moritz Vollrath, et al.
Mabs|March 9, 2026
NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody-antigen interactionsDawid Chomicz, Paweł Dudzic, Sonia Wrobel, et al.
Mabs|February 26, 2026
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHORajesh K Mistry, Chendi Nui, Giulia Lambiase, et al.
Mabs|March 10, 2026
Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinomaDanlin Yang, Neha Kamran, Gururaj Shivange, et al.
Pageof 180